The Effects of Chronic Lymphocytic Thyroiditis on Clinicopathologic Factors in Papillary Thyroid Cancer

Davies, 2014, Current thyroid cancer trends in the United States, JAMA Otolaryngol Head Neck Surg, 140, 317, 10.1001/jamaoto.2014.1 Hodgson, 2004, Thyroid cancer: is the incidence still increasing?, Ann Surg Oncol, 11, 1093, 10.1245/ASO.2004.03.066 Sherman, 2003, Thyroid carcinoma, Lancet, 361, 501, 10.1016/S0140-6736(03)12488-9 Siegel, 2015, Cancer statistics, 2015, CA Cancer J Clin, 65, 5, 10.3322/caac.21254 Powers, 2019, Changes in trends in thyroid cancer incidence in the United States, 1992 to 2016, JAMA, 322, 2440, 10.1001/jama.2019.18528 Antonelli, 2015, Autoimmune thyroid disorders, Autoimmun Rev, 14, 174, 10.1016/j.autrev.2014.10.016 Caturegli, 2014, Hashimoto thyroiditis: clinical and diagnostic criteria, Autoimmun Rev, 13, 391, 10.1016/j.autrev.2014.01.007 McLeod, 2012, The incidence and prevalence of thyroid autoimmunity, Endocrine, 42, 252, 10.1007/s12020-012-9703-2 Ragusa, 2019, Hashimotos’ thyroiditis: epidemiology, pathogenesis, clinic and therapy, Best Pract Res Clin Endocrinol Metab, 33, 101367, 10.1016/j.beem.2019.101367 Babli, 2018, Effects of chronic lymphocytic thyroiditis on the clinicopathological features of papillary thyroid cancer, Eur Thyroid J, 7, 95, 10.1159/000486367 Zhang, 2012, The clinical features of papillary thyroid cancer in Hashimoto’s thyroiditis patients from an area with a high prevalence of Hashimoto’s disease, BMC Cancer, 12, 610, 10.1186/1471-2407-12-610 Donangelo, 2016, Lymphocytic thyroiditis is associated with increased number of benign cervical nodes and fewer central neck compartment metastatic lymph nodes in patients with differentiated thyroid cancer, Endocr Pract, 22, 1192, 10.4158/E151078.OR Jara, 2013, The relationship between chronic lymphocytic thyroiditis and central neck lymph node metastasis in North American patients with papillary thyroid carcinoma, Surgery, 154, 1272, 10.1016/j.surg.2013.07.021 Del Rio, 2008, The association between papillary carcinoma and chronic lymphocytic thyroiditis: does it modify the prognosis of cancer?, Minerva Endocrinol, 33, 1 Kebebew, 2001, Coexisting chronic lymphocytic thyroiditis and papillary thyroid cancer revisited, World J Surg, 25, 632, 10.1007/s002680020165 Kimura, 1992, Interleukin-1 inhibits human thyroid carcinoma cell growth, J Clin Endocrinol Metab, 75, 596 Lucas, 1996, Tumor-specific deposition of immunoglobulin G and complement in papillary thyroid carcinoma, Hum Pathol, 27, 1329, 10.1016/S0046-8177(96)90346-9 Kashima, 1998, Chronic thyroiditis as a favorable prognostic factor in papillary thyroid carcinoma, Thyroid, 8, 197, 10.1089/thy.1998.8.197 Dvorkin, 2013, Differentiated thyroid cancer is associated with less aggressive disease and better outcome in patients with coexisting Hashimotos thyroiditis, J Clin Endocrinol Metab, 98, 2409, 10.1210/jc.2013-1309 Haugen, 2016, 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer, Thyroid, 26, 1, 10.1089/thy.2015.0020 2017 Dailey, 1955, Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland, AMA Arch Surg, 70, 291, 10.1001/archsurg.1955.01270080137023 Aydoğan, 2021, The association of histologically proven chronic lymphocytic thyroiditis with clinicopathological features, lymph node metastasis, and recurrence rates of differentiated thyroid cancer, Endocr Pathol, 32, 280, 10.1007/s12022-020-09653-y Qu, 2016, The impact of coexistent Hashimoto’s thyroiditis on lymph node metastasis and prognosis in papillary thyroid microcarcinoma, Tumour Biol, 37, 7685, 10.1007/s13277-015-4534-4 Moon, 2018, Associations between Hashimoto thyroiditis and clinical outcomes of papillary thyroid cancer: a meta-analysis of observational studies, Endocrinol Metab (Seoul), 33, 473, 10.3803/EnM.2018.33.4.473 Xu, 2018, Crucial parameters in thyroid carcinoma reporting—challenges, controversies and clinical implications, Histopathology, 72, 32, 10.1111/his.13335 Pontius, 2016, Lymphovascular invasion is associated with survival for papillary thyroid cancer, Endocr Relat Cancer, 23, 555, 10.1530/ERC-16-0123 Rowe, 2020, Innervation of papillary thyroid cancer and its association with extra-thyroidal invasion, Sci Rep, 10, 1539, 10.1038/s41598-020-58425-5 Lee, 2013, The association between papillary thyroid carcinoma and histologically proven Hashimoto’s thyroiditis: a meta-analysis, Eur J Endocrinol, 168, 343, 10.1530/EJE-12-0903 Lee, 2020, The association between chronic lymphocytic thyroiditis and the progress of papillary thyroid cancer, World J Surg, 44, 1506, 10.1007/s00268-019-05337-9 Ganly, 2015, Survival from differentiated thyroid cancer: what has age got to do with it?, Thyroid, 25, 1106, 10.1089/thy.2015.0104 Bischoff, 2013, Is above age 45 appropriate for upstaging well-differentiated papillary thyroid cancer?, Endocr Pract, 19, 995, 10.4158/EP13029.OR Liu, 2017, Hashimoto’s thyroiditis is an important risk factor of papillary thyroid microcarcinoma in younger adults, Horm Metab Res, 49, 732, 10.1055/s-0043-117892 Ehlers, 2014, Hashimoto’s thyroiditis and papillary thyroid cancer: are they immunologically linked?, Trends Endocrinol Metab, 25, 656, 10.1016/j.tem.2014.09.001 Muzza, 2010, The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies, Clin Endocrinol (Oxf), 72, 702, 10.1111/j.1365-2265.2009.03699.x Zeppa, 2009, Cytologic, flow cytometry, and molecular assessment of lymphoid infiltrate in fine-needle cytology samples of Hashimoto thyroiditis, Cancer, 117, 174 Chui, 2013, Follicular epithelial dysplasia of the thyroid: morphological and immunohistochemical characterization of a putative preneoplastic lesion to papillary thyroid carcinoma in chronic lymphocytic thyroiditis, Virchows Arch, 462, 557, 10.1007/s00428-013-1397-1 Fiore, 2012, Serum TSH and risk of papillary thyroid cancer in nodular thyroid disease, J Clin Endocrinol Metab, 97, 1134, 10.1210/jc.2011-2735 Lee, 2011, Recurrence of papillary thyroid carcinoma in a remnant pyramidal lobe, ANZ J Surg, 81, 10.1111/j.1445-2197.2011.05687.x Cunha, 2012, Infiltration of a mixture of immune cells may be related to good prognosis in patients with differentiated thyroid carcinoma, Clin Endocrinol (Oxf), 77, 918, 10.1111/j.1365-2265.2012.04482.x Kim, 2009, Clinical and pathological features and the BRAF(V600E) mutation in patients with papillary thyroid carcinoma with and without concurrent Hashimoto thyroiditis, Thyroid, 19, 137, 10.1089/thy.2008.0144 Rotondi, 2013, CXCL8 in thyroid disease: from basic notions to potential applications in clinical practice, Cytokine Growth Factor Rev, 24, 539, 10.1016/j.cytogfr.2013.08.001